scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.25907 |
P698 | PubMed publication ID | 22711685 |
P2093 | author name string | Zheng Wang | |
Jian Zhou | |||
Jia Fan | |||
Zhi Dai | |||
Xiao-Wu Huang | |||
Xiao-Ying Wang | |||
Shao-Lai Zhou | |||
Zheng-Jun Zhou | |||
Guo-Huan Yang | |||
P2860 | cites work | Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis | Q24633862 |
An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients | Q24672958 | ||
Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 | Q24675647 | ||
Cancer statistics, 2010 | Q27860525 | ||
Cancer-related inflammation | Q27860907 | ||
Neutrophil serine proteases: specific regulators of inflammation | Q28248366 | ||
Cancer and the chemokine network | Q28269751 | ||
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth | Q28270711 | ||
Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
The role of myeloid cells in the promotion of tumour angiogenesis | Q29614299 | ||
Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer | Q30427989 | ||
A decade's studies on metastasis of hepatocellular carcinoma | Q35611503 | ||
CXCL5 promotes prostate cancer progression | Q36487549 | ||
Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-{kappa}B activation in neutrophils exposed to chemotactic cytokines | Q36559688 | ||
Molecular targeted therapies in hepatocellular carcinoma | Q37003665 | ||
Immune cells as mediators of solid tumor metastasis | Q37027344 | ||
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer | Q37384020 | ||
The chemokine system in cancer biology and therapy | Q37651839 | ||
Chemokines and chemokine receptors: new insights into cancer-related inflammation. | Q37694068 | ||
Emerging mechanisms of neutrophil recruitment across endothelium | Q37916958 | ||
Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms | Q38354220 | ||
CXCL5/ENA78 increased cell migration and epithelial‐to‐mesenchymal transition of hormone‐independent prostate cancer by early growth response‐1/snail signaling pathway | Q39644372 | ||
Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. | Q39800555 | ||
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer | Q39853277 | ||
Down-regulation of CXCL5 inhibits squamous carcinogenesis. | Q40291604 | ||
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis | Q40320652 | ||
Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression | Q40365774 | ||
Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study | Q42473726 | ||
Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease | Q45863625 | ||
Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells | Q47806288 | ||
CXCL5 overexpression is associated with late stage gastric cancer. | Q53555447 | ||
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. | Q54576030 | ||
Inflaming metastasis | Q56942551 | ||
Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection | Q79690945 | ||
Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases | Q81919887 | ||
Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection | Q82641830 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 2242-2254 | |
P577 | publication date | 2012-12-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma | |
P478 | volume | 56 |
Q92747215 | A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression |
Q34612497 | A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients |
Q58593551 | Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways |
Q34256150 | Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy |
Q34323663 | CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma |
Q49268237 | CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells |
Q40936667 | CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients |
Q90576901 | CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration |
Q97423265 | CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils |
Q52662320 | CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. |
Q36210826 | CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. |
Q92935558 | CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma |
Q55324076 | Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. |
Q34932446 | Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition |
Q35668771 | Chemokines and their receptors play important roles in the development of hepatocellular carcinoma |
Q48210146 | Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. |
Q29994573 | Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? |
Q90458156 | Development of an immune-related prognostic index associated with hepatocellular carcinoma |
Q35758694 | Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells |
Q55127228 | Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma. |
Q36785760 | EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway |
Q59125682 | Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification |
Q90403237 | Expression of Programmed Cell Death-Ligands in Hepatocellular Carcinoma: Correlation With Immune Microenvironment and Survival Outcomes |
Q35215701 | Fibroblast α11β1 integrin regulates tensional homeostasis in fibroblast/A549 carcinoma heterospheroids |
Q60046358 | Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease |
Q38814227 | HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma |
Q40917751 | High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma |
Q36767227 | Host Cxcr2-dependent regulation of mammary tumor growth and metastasis |
Q92184088 | IDO and intra-tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma |
Q92683646 | Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis |
Q107377157 | Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients |
Q102379530 | Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells |
Q37152937 | Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model |
Q36243383 | Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma |
Q41595426 | Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment |
Q92451135 | Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response |
Q36073222 | Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. |
Q28080281 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention |
Q91584509 | Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy |
Q46931825 | Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice |
Q91644938 | MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling |
Q87347005 | NORE1A sensitises cancer cells to sorafenib-induced apoptosis and indicates hepatocellular carcinoma prognosis |
Q33648502 | Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients |
Q87509976 | Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma |
Q38678088 | Neutrophils in the Tumor Microenvironment |
Q33816141 | Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. |
Q39011826 | One microenvironment does not fit all: heterogeneity beyond cancer cells |
Q37588358 | Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection |
Q36298565 | Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma |
Q64062210 | Preoperative systemic inflammatory markers in low- and high-grade gliomas: A retrospective analysis of 171 patients |
Q55209569 | Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. |
Q35660696 | Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis |
Q35161694 | Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis |
Q38046098 | Protumor and antitumor functions of neutrophil granulocytes |
Q41151392 | Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors |
Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
Q33897910 | Roles of CXCL5 on migration and invasion of liver cancer cells |
Q35674182 | Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence. |
Q44536329 | Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma |
Q47922873 | Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. |
Q48583884 | Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma |
Q52582455 | The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. |
Q36343870 | The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response |
Q36179636 | The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression |
Q28241308 | The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment |
Q57816901 | The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity |
Q47101861 | The clinical significance of CXCL5 in non-small cell lung cancer |
Q37595291 | The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment |
Q26864040 | The role of neutrophils in the development of liver diseases |
Q38925831 | Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology |
Q90266601 | Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma |
Q91675408 | Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy |
Q37089248 | Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils |
Q33721221 | Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis |
Q57183696 | Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration |
Q90468410 | Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma |
Q92502928 | Tumour-associated neutrophils in patients with cancer |
Q38800302 | Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance |
Q90608638 | miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop |
Q38804742 | miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis |
Q55252304 | microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. |
Q35048745 | β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling |
Search more.